Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 16 results:
Author Title Type [ Year
] Filters: Keyword is Drug Resistance [Clear All Filters]
(2017). Can we create a valid treatment algorithm for patients with drug resistant overactive bladder (OAB) syndrome or detrusor overactivity (DO)? Results from a think tank (ICI-RS 2015)..
Neurourol Urodyn. 36(4), 882-893.
(2017). Drk-mediated signaling to Rho kinase is required for anesthesia-resistant memory in ..
Proc Natl Acad Sci U S A. 114(41), 10984-10989.
(2017). FCGR3A-V158F polymorphism is a disease-specific pharmacogenetic marker for the treatment of psoriasis with Fc-containing TNFα inhibitors..
Pharmacogenomics J. 17(3), 237-241.
(2015). Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial..
Hum Reprod. 30(2), 432-40.
(2014). Carotid baroreceptor stimulation: a promising approach for the management of resistant hypertension and heart failure..
Curr Vasc Pharmacol. 12(1), 30-7.
(2014). Comparative epidemiology of resistant hypertension in chronic kidney disease and the general hypertensive population..
Semin Nephrol. 34(5), 483-91.
(2014). Dynamic resistant hypertension patterns as predictors of cardiovascular morbidity: a 4-year prospective study..
J Hypertens. 32(2), 415-22.
(2014). Ferroportin in monocytes of hemodialysis patients and its associations with hepcidin, inflammation, markers of iron status and resistance to erythropoietin..
Int Urol Nephrol. 46(1), 161-7.
(2014). Renal denervation: transition from pathophysiology to clinical practice..
Angiology. 65(9), 760-8.
(2014). The role of renal nerve ablation for the management of resistant hypertension and other disease conditions: benefits and concerns..
Curr Vasc Pharmacol. 12(1), 38-46.
(2014). Surgical septal myectomy for hypertrophic cardiomyopathy in Greece: a single-center initial experience..
Hellenic J Cardiol. 55(2), 132-8.
(2013). Can a single inflammatory marker adequately predict resistance to erythropoiesis-stimulating agents in hemodialysis patients?.
Hemodial Int. 17(1), 130-1.
(2011). Epidemiology of resistant hypertension..
J Clin Hypertens (Greenwich). 13(7), 523-8.
(2011). Renal sympathetic denervation in hypertension..
Curr Opin Nephrol Hypertens. 20(6), 647-53.
(2009). The prognostic value of serum chromogranin A and prostate specific antigen in prostate cancer patients for progression to the hormone resistance state..
Hell J Nucl Med. 12(3), 234-7.
